You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Medscape Conference Coverage, based on selected sessions at the:

American College of Rheumatology (ACR) 2008 Annual Scientific Meeting

October 24 - 29, 2008; San Francisco, California

This activity is not sanctioned by, nor a part of, the American College of Rheumatology. Conference news does not receive grant support and is produced independently.

Topic Overviews

    • Gout: Adverse Events and Quality-of-Life Issues -- Update From ACR 2008
      Alan K. Matsumoto, MD, FACR
    • Pathophysiology and Risk Factors for Gout: Update From ACR 2008
      Herbert S. Baraf, MD; Becky McCall, Msc
    • Recent Advances in Difficult-to-Treat Gout: An Expert Interview With Robert A. Terkeltaub, MD
      Helen Fosam, PhD
    • Lipids and Cardiovascular Risk in Rheumatoid Arthritis
      Yusuf Yazici, MD
    • Risks and Adverse Events Associated With Biologic Agents for Rheumatoid Arthritis
      Marc C. Levesque, MD, PhD
    • Patient-Reported Outcomes as Measures of Responsiveness in Patients With Rheumatic Disease: Update From ACR 2008
      Lee S. Simon, MD
    • Antitumor Necrosis Factor Agents: Safety, Efficacy, and New Advances
      Arthur Kavanaugh, MD
    • Spondyloarthropathies: Treatment Advances From ACR 2008
      Muhammad A. Khan, MD
    • Predicting Treatment Response to Antitumor Necrosis Factor Agents: An Update From ACR 2008
      Robert I. Fox, MD, PhD; Carla M. Fox, RN
    • Treatment Adherence and Quality of Care for Gout: Update From ACR 2008
      Robert Terkeltaub, MD
    • Gout: Becoming Interesting Again -- Update From ACR 2008
      Lee S. Simon, MD
    • Hyperuricemia and Gout -- Implications of Recent Advances on Outcomes: An Expert Interview With Michael A. Becker, MD
      Michael A. Becker, MD; Helen Fosam, PhD
    • Treatment Advances for Systemic Lupus Erythematosus: An Update From ACR 2008
      Doruk Erkan, MD
    • Update on Pediatric Rheumatic Diseases From ACR 2008
      Tadej Avcin, MD, PhD
    • Update on Sjögren's Syndrome From ACR 2008
      Robert I. Fox, MD, PhD; Carla M. Fox, RN

Conference Spotlight

  • Drs. Strand, Terkeltaub, and Saag discuss the increasing incidence of gout, the challenges of its treatment, and some of the recent therapeutic advances.

Expert Interview

  • An Expert Interview With Philip J. Mease, MD
    Philip J. Mease, MD, Chief of Rheumatology Research and Clinical Professor of Medicine, University of Washington, Seattle, discusses recent advances with anti-TNF agents for RA.
  • An Expert Interview With Allan Gibofsky, MD, JD
    Allan Gibofsky, MD, Professor of Medicine and Public Health, Weill Medical College, New York, NY, discusses recent advances in the therapeutic management of RA.
  • Robert Terkeltaub, MD, discusses the current and emerging management approach for difficult-to-treat gout, according to data from ACR 2008.
  • Michael Becker, MD, Professor Emeritus of Medicine, University of Chicago, discusses recent advances in the therapeutic management of hyperuricemia and gout, as illustrated by data from ACR 2008.